CLINICAL AND HISTOLOGICAL FACTORS PREDICTIVE OF RESPONSE TO ERLOTINIB (TARCEVA (R)) IN ADVANCED NSCLC: THE EXPERIENCE OF A SINGLE INSTITUTION. FROM CLINICAL TRIALS TO BED SIDE
- Resource Type
- Journal
- Source
ANNALS OF ONCOLOGY ; OCT 2009, 20 1p. Supplement: 8- Subject
- Language
- English
- ISSN
- 09237534